NEW YORK, Aug. 4, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
Microneedle technology is an enabling technology base for the development of needles with micro scale cross sectional dimensions and added functionality. The microneedles can be used for conventional drug delivery and sample extraction applications as well as for integration with other miniaturized biochemical analysis systems. The needles are enabling for the manipulation of micro volumes of samples as well as for parallel distribution of samples or reagents on a close center-to-center spacing. The commercialization of microneedle drug delivery devices such as the sanofi-aventis Intanza influenza vaccine, which is based on the Becton Dickinson Soluvia syringe-mounted microneedle array device, is a milestone in the transition of microneedle drug delivery from development to market place. Microneedle technology promises to impact health care by allowing the precise injection of therapeutic agents to prescribed locations below the skin.
• Analyzes and evaluates microneedle technology and product research and development, and assesses the medical market potential for existing and probable future products
• Analyzes proprietary technologies and market develop